The value of persistence in treatment with subcutaneous TNF-alpha inhibitors for ankylosing spondylitis

Objective To estimate the impact of persistence on cost-effectiveness of subcutaneous tumor necrosis factor-α inhibitors (SC-TNFis) from healthcare and societal perspectives in a United Kingdom ankylosing spondylitis (AS) population using a recently published Markov cohort model. Methods A recently...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The European journal of health economics 2020-02, Vol.21 (1), p.45-54
Hauptverfasser:	Svedbom, Axel, Dalén, Johan, Ivergård, Moa, Borse, Rebekah H., Black, Christopher M., Luttropp, Karin, Kachroo, Sumesh
Format:	Artikel
Sprache:	eng
Schlagworte:	Arthritis Cost analysis Cost-Benefit Analysis Economic Policy Female Health care Health Care Management Health Economics Humans Injections, Subcutaneous Male Markov Chains Medication Adherence - statistics & numerical data Medicine Medicine & Public Health Models, Econometric Original Paper Pharmacoeconomics and Health Outcomes Public Finance Public Health Quality-Adjusted Life Years Severity of Illness Index Spondylitis, Ankylosing - drug therapy TNF inhibitors Tumor Necrosis Factor Inhibitors - administration & dosage Tumor Necrosis Factor Inhibitors - economics Tumor Necrosis Factor Inhibitors - therapeutic use Tumor necrosis factor-TNF United Kingdom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!